Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics (RAPT) Operating Expenses (2020 - 2023)

Historic Operating Expenses for Therapeutics (RAPT) over the last 4 years, with Q4 2023 value amounting to $33.2 million.

  • Therapeutics' Operating Expenses rose 3596.25% to $33.2 million in Q4 2023 from the same period last year, while for Sep 2024 it was $33.2 million, marking a year-over-year decrease of 7191.57%. This contributed to the annual value of $127.1 million for FY2023, which is 4550.97% up from last year.
  • Therapeutics' Operating Expenses amounted to $33.2 million in Q4 2023, which was up 3596.25% from $33.9 million recorded in Q3 2023.
  • Therapeutics' 5-year Operating Expenses high stood at $33.9 million for Q3 2023, and its period low was $13.8 million during Q2 2020.
  • For the 4-year period, Therapeutics' Operating Expenses averaged around $21.6 million, with its median value being $19.6 million (2021).
  • In the last 5 years, Therapeutics' Operating Expenses surged by 1117.49% in 2022 and then soared by 5646.74% in 2023.
  • Over the past 4 years, Therapeutics' Operating Expenses (Quarter) stood at $14.4 million in 2020, then soared by 30.6% to $18.8 million in 2021, then surged by 30.02% to $24.4 million in 2022, then skyrocketed by 35.96% to $33.2 million in 2023.
  • Its Operating Expenses was $33.2 million in Q4 2023, compared to $33.9 million in Q3 2023 and $28.4 million in Q2 2023.